Sale!

DSC2 Gene Arrhythmogenic Right Ventricular Cardiomyopathy Type 11 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The DSC2 Gene Arrhythmogenic Right Ventricular Cardiomyopathy Type 11 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to detect mutations in the DSC2 gene, which are associated with Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Type 11. ARVC is a form of heart disease that affects the muscle of the right ventricle, leading to arrhythmias and heart failure. The condition is genetic and can be passed down through families.

The test is particularly crucial for individuals with a family history of ARVC or unexplained cardiac symptoms, as early detection can significantly influence management and treatment options. By analyzing the patient’s DNA, the test identifies specific mutations in the DSC2 gene that are known to contribute to the development of this condition, providing valuable information for clinical decisions.

Priced at 4400 AED, the test is conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities and commitment to providing accurate, confidential, and comprehensive diagnostic services. The cost reflects the intricate technology and expertise required to perform such specialized genetic analysis. This test is an essential tool in the arsenal against ARVC, offering hope and direction for affected individuals and their families in managing this challenging condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

DSC2 Gene Arrhythmogenic right ventricular cardiomyopathy type 11 Genetic Test

At DNA Labs UAE, we offer the DSC2 Gene Arrhythmogenic right ventricular cardiomyopathy type 11 Genetic Test for AED 4400.0. This test is used to diagnose and identify potential disease-causing variants or mutations in the DSC2 gene associated with arrhythmogenic right ventricular cardiomyopathy (ARVC).

Test Details

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a condition characterized by the replacement of normal heart muscle tissue with fibrous or fatty tissue in the right ventricle. This can lead to abnormal heart rhythms and potentially life-threatening arrhythmias.

Our NGS (Next-Generation Sequencing) technology allows us to analyze multiple genes simultaneously, including the DSC2 gene, to identify mutations or variants that may be responsible for the development of ARVC type 11. By analyzing the individual’s DNA, NGS testing can provide valuable information about their genetic predisposition to ARVC type 11.

Early diagnosis through genetic testing can help with risk assessment and potentially guide treatment decisions. However, it is important to note that genetic testing should always be done under the guidance of a healthcare professional who can interpret the results and provide appropriate counseling and medical management.

Test Components and Price

The DSC2 Gene Arrhythmogenic right ventricular cardiomyopathy type 11 Genetic Test is priced at AED 4400.0. The test can be conducted using a blood sample, extracted DNA, or one drop of blood on an FTA card.

Report Delivery and Method

The report for the DSC2 Gene Arrhythmogenic right ventricular cardiomyopathy type 11 Genetic Test will be delivered within 3 to 4 weeks. The test is performed using NGS technology, which allows for efficient and accurate analysis of multiple genes simultaneously.

Test Type and Doctor

The DSC2 Gene Arrhythmogenic right ventricular cardiomyopathy type 11 Genetic Test falls under the category of Cardiovascular Pneumology Disorders. It is recommended to consult with a Cardiologist for this test.

Test Department and Pre Test Information

The DSC2 Gene Arrhythmogenic right ventricular cardiomyopathy type 11 Genetic Test is conducted in our Genetics department. Before undergoing the test, it is important to provide the clinical history of the patient and participate in a Genetic Counselling session to draw a pedigree chart of family members affected by ARVC type 11.

Genetic counselling and pedigree analysis help in understanding the inheritance pattern and identifying potential carriers of the DSC2 gene mutation.

At DNA Labs UAE, we strive to provide accurate and reliable genetic testing services. Our DSC2 Gene Arrhythmogenic right ventricular cardiomyopathy type 11 Genetic Test can provide valuable insights into an individual’s genetic predisposition to ARVC type 11, aiding in early diagnosis and personalized treatment plans.

Test Name DSC2 Gene Arrhythmogenic right ventricular cardiomyopathy type 11 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cardiovascular Pneumology Disorders
Doctor Cardiologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for DSC2 Gene Arrhythmogenic right ventricular cardiomyopathy type 11 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with DSC2 Gene Arrhythmogenic right ventricular cardiomyopathy type 11 NGS Genetic DNA Test gene DSC2
Test Details

The DSC2 gene is associated with arrhythmogenic right ventricular cardiomyopathy (ARVC), a condition characterized by the replacement of normal heart muscle tissue with fibrous or fatty tissue in the right ventricle. This can lead to abnormal heart rhythms and potentially life-threatening arrhythmias.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify potential disease-causing variants or mutations. In the context of ARVC type 11, NGS genetic testing can be used to identify mutations or variants in the DSC2 gene that may be responsible for the development of the condition.

By analyzing the individual’s DNA, NGS testing can provide valuable information about their genetic predisposition to ARVC type 11. This can help with early diagnosis, risk assessment, and potentially guide treatment decisions.

It is important to note that genetic testing should always be done under the guidance of a healthcare professional who can interpret the results and provide appropriate counseling and medical management.